BERNARDINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 111
EU - Europa 51
AS - Asia 34
AF - Africa 18
Totale 214
Nazione #
US - Stati Uniti d'America 111
IT - Italia 25
SG - Singapore 20
SE - Svezia 16
CI - Costa d'Avorio 14
CN - Cina 6
IN - India 5
BG - Bulgaria 4
GB - Regno Unito 3
SN - Senegal 3
VN - Vietnam 2
CZ - Repubblica Ceca 1
FR - Francia 1
HK - Hong Kong 1
NG - Nigeria 1
UA - Ucraina 1
Totale 214
Città #
Abidjan 14
Chandler 13
Fairfield 12
Singapore 9
Boardman 7
Florence 7
New York 6
Seattle 6
Ashburn 5
Houston 5
Cambridge 4
Hyderabad 4
Lawrence 4
Princeton 4
Sofia 4
Woodbridge 4
Ann Arbor 3
Bologna 3
Dakar 3
Pisa 3
Quanzhou 3
Santa Croce sull'Arno 3
Wilmington 3
London 2
Lucca 2
Medford 2
Milan 2
Santa Clara 2
Turin 2
Brno 1
Fuzhou 1
Hangzhou 1
Hong Kong 1
Kelvedon 1
Kent 1
Lagos 1
Marseille 1
Modena 1
New Delhi 1
North Charleston 1
Ogden 1
Salem 1
San Diego 1
Shanghai 1
Totale 156
Nome #
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age? 62
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 49
Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle 32
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients 31
Equivalent efficacy but different safety profiles of gemcitabine plus nab-paclitaxel and folfirinox in metastatic pancreatic cancer 29
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology 13
Robotic Versus Open Pancreatoduodenectomy With Vein Resection and Reconstruction: A Propensity Score-Matched Analysis 9
Totale 225
Categoria #
all - tutte 1.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 35 1 0 2 1 0 6
2021/202226 0 0 0 0 3 7 2 0 1 4 3 6
2022/202374 6 8 6 0 4 13 1 7 23 0 4 2
2023/202450 2 4 5 0 4 5 13 1 0 5 2 9
2024/202530 3 11 11 5 0 0 0 0 0 0 0 0
Totale 225